EDGAR Filing Documents for 0001140361-23-048195

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001140361-23-048195

Filing Date

2023-10-13

Accepted

2023-10-13 16:25:32

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3/A	ny20009756x2_s3a.htm	S-3/A	377233
2	EXHIBIT 5.1	ny20009756x2_ex5-1.htm	EX-5.1	12503
3	EXHIBIT 23.1	ny20009756x2_ex23-1.htm	EX-23.1	2352
4	EXHIBIT 23.2	ny20009756x2_ex23-2.htm	EX-23.2	2431
5		logo_catalystbiox1.jpg	GRAPHIC	70509
6		logo_catalystbiox2.jpg	GRAPHIC	40022
7		ny20009756x2_ex5-1logo.jpg	GRAPHIC	2674
	Complete submission text file	0001140361-23-048195.txt		551292

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080

Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761

CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-273395 | Film No.: 231325307
SIC: 2834 Pharmaceutical Preparations